AMICUS THERAPEUTICS, INC. Financial and Nonfinancial Liabilities, Fair Value Disclosure
AMICUS THERAPEUTICS, INC. had Financial and Nonfinancial Liabilities, Fair Value Disclosure of $2.08 million as of 2025-09-30, per its 10-Q filed 2025-11-04.
Financial Statements › Notes › Fair Value Disclosures › Fair Value, Net Asset (Liability)
us-gaap:LiabilitiesFairValueDisclosure · last filed 2025-11-04
- 2025-09-30: Financial and Nonfinancial Liabilities, Fair Value Disclosure $2.08M.
- 2025-06-30: Financial and Nonfinancial Liabilities, Fair Value Disclosure $2.18M.
- 2025-03-31: Financial and Nonfinancial Liabilities, Fair Value Disclosure $2.06M.
- 2024-12-31: Financial and Nonfinancial Liabilities, Fair Value Disclosure $2.22M.
| Period end | Financial and Nonfinancial Liabilities, Fair Value Disclosure |
|---|---|
| 2025-09-30 | $2.08M 10-Q · filed 2025-11-04 |
| 2025-06-30 | $2.18M 10-Q · filed 2025-07-31 |
| 2025-03-31 | $2.06M 10-Q · filed 2025-05-01 |
| 2024-12-31 | $2.22M 10-Q · filed 2025-11-04 |
| 2024-09-30 | $7.82M 10-Q · filed 2024-11-06 |
| 2024-06-30 | $7.34M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $7.10M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $7.53M 10-K · filed 2025-02-19 |
| 2023-09-30 | $6.72M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $19.79M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $18.95M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $26.88M 10-K · filed 2024-02-28 |
| 2022-09-30 | $24.84M 10-Q · filed 2022-11-07 |
| 2022-06-30 | $24.24M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $24.56M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $25.14M 10-K · filed 2023-03-01 |
| 2021-09-30 | $28.99M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $31.55M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $30.24M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $29.90M 10-K · filed 2022-02-24 |
| 2020-09-30 | $28.95M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $27.64M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $26.67M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $27.10M 10-K · filed 2021-03-01 |
| 2019-09-30 | $26.04M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $25.12M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $24.38M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $22.43M 10-K · filed 2020-03-02 |
| 2018-09-30 | $31.10M 10-Q · filed 2018-11-05 |
| 2018-06-30 | $29.53M 10-Q · filed 2018-08-07 |
| 2018-03-31 | $109.57M 10-Q · filed 2018-05-09 |
| 2017-12-31 | $27.66M 10-K · filed 2019-02-28 |
| 2017-09-30 | $23.23M 10-Q · filed 2017-11-08 |
| 2017-06-30 | $267.34M 10-Q · filed 2017-08-07 |
| 2017-03-31 | $276.25M 10-Q · filed 2017-05-09 |
| 2016-12-31 | $271.47M 10-K · filed 2018-03-01 |
| 2016-09-30 | $273.86M 10-Q · filed 2016-11-07 |
| 2016-06-30 | $277.84M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $278.27M 10-Q · filed 2016-05-03 |
| 2015-12-31 | $274.74M 10-K/A · filed 2017-03-03 |
| 2015-09-30 | $283.52M 10-Q · filed 2015-11-04 |
| 2014-12-31 | $11.16M 10-Q · filed 2015-11-04 |